Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Therapeutic Response and Survival of Patients with Metastatic Colorectal Cancer (stage IV) and Treated According to the Guidelines of a Chemosensitivity Test, Oncogramme®

NCT03133273 is registered in ClinicalTrials.gov with University Hospital, Limoges as lead sponsor.

NCT NCT03133273
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03133273 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Therapeutic Response and Survival of Patients with Metastatic Colorectal Cancer (stage IV) and Treated According to the Guidelines of a Chemosensitivity Test, Oncogramme®
Lead sponsor
University Hospital, Limoges
Phase
Not applicable
Overall status
Completed
Start date
July 24, 2017
Completion date
April 3, 2024
Enrollment
256 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy, colorectal cancer metastatic